- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.06. | Galderma shares positive two-year results for Nemluvio in atopic dermatitis | ||
| 11.06. | Darwin's dictum on data | ||
| 10.06. | Merck's RSV monoclonal antibody Enflonsia approved by FDA to protect infants | ||
| 10.06. | Alnylam's Amvuttra granted EC approval to treat rare heart disease ATTR-CM | ||
| 10.06. | Sobi/Apellis' pegcetacoplan shows sustained efficacy in phase 3 kidney disease study | ||
| 10.06. | PM Society and the Chartered Institute of Marketing announce partnership | ||
| 10.06. | Shaping the future of cancer care | ||
| 09.06. | The transformative role of AI in the future of healthcare communications | ||
| 09.06. | MHRA approves SFL's Aumseqa to treat EGFR-mutated lung cancer in adults | ||
| 09.06. | Otsuka shares promising phase 3 results for sibeprenlimab in rare kidney disease IgAN | ||
| 09.06. | Improving patients' mental health: the role of healthcare comms | ||
| 09.06. | The outlook for healthcare comms in 2025 | ||
| 06.06. | Eli Lilly and Camurus enter cardiometabolic health partnership worth up to $870m | ||
| 06.06. | AstraZeneca's Calquence approved by EC for first-line chronic lymphocytic leukaemia use | ||
| 06.06. | Conferences: the value of real experience versus virtual convenience | ||
| 06.06. | The power of creativity in healthcare PR | ||
| 05.06. | Roche's Evrysdi tablets granted EC approval to treat spinal muscular atrophy | ||
| 05.06. | VML Health appoints Nick Bartlett as chief executive officer of EU hub | ||
| 05.06. | Essential agility in an era of change for medical affairs | ||
| 05.06. | How AI can humanise data and transform healthcare communications | ||
| 04.06. | Regeneron gains rights to Hansoh's GLP-1/GIP receptor agonist in deal worth $2bn | ||
| 04.06. | Takeda receives EC approval for Adcetris combination in Hodgkin lymphoma | ||
| 04.06. | Dermaliq and DEBRA partner to advance epidermolysis bullosa drug delivery | ||
| 04.06. | Inizio Evoke appoints Matthew Hoelzle as chief medical officer | ||
| 04.06. | Building inclusive clinical trials through policy reform |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .